ABSTRACT BACKGROUND: We aimed to develop and validate a practical instrument to assess older adults’ satisfaction with their social participation (SP). DESIGN AND SETTING: This methodological validation study was conducted at a public higher education institution. METHODS: A two-phase study was designed, developed, and validated to assess older adults’ satisfaction with their SP. In the first phase, we conceptualized SP and developed an “instrument to assess older adults’ satisfaction with their SP (IAPSI),” as approved by a committee of specialists, pre-tested, and partially validated. Second, we determined the IAPSI’s reproducibility using Cronbach’s alpha to measure internal consistency, Pearson’s and Spearman’s coefficients to measure correlations, the Bland-Altman plot and intraclass correlation coefficient (ICC) to measure reproducibility. We also generated a receiver operating characteristic (ROC) curve. RESULTS: 102 older adults (mean age, 87.29) participated in the first phase. Moderate internal consistency (Cronbach’s alpha 0.7) and significant moderate correlations with quality of life by World Health Organization Quality of Life (WHOQOL)-bref and by WHOQOL-old social domains (Pearson’s coefficients 0.54 and 0.64, respectively; P < 0.001) were found. The ROC curve indicated an IAPSI score of 17 as the threshold for the impact of pain on satisfaction with SP (83.3% sensitivity and 88.9% specificity, P < 0.001). In the second phase, 56 older adults (between 81 and 90 years old) participated. We found adequate intra- and inter-observer reproducibility for the IAPSI (ICC 0.96 and 0.78, respectively). CONCLUSION: We have developed a practical instrument with appropriate psychometric properties to assess older adults’ satisfaction with their SP. BACKGROUND . (SP) SETTING institution METHODS twophase two phase designed IAPSI, , (IAPSI), specialists pretested, pretested pre tested, tested pre-tested Second IAPSIs s Cronbachs Cronbach Pearsons Pearson Spearmans Spearman BlandAltman Bland Altman ICC (ROC RESULTS 10 mean age 87.29 8729 87 29 0.7 07 0 7 WHOQOLbref WHOQOL bref WHOQOLold old 054 54 0.5 064 64 0.64 respectively 0.001 0001 001 1 83.3% 833 83 3 (83.3 889 88 9 88.9 specificity 0.001. 5 between 8 intra interobserver inter observer 096 96 0.9 078 78 0.78 respectively. respectively) CONCLUSION (SP (IAPSI) 87.2 872 2 0. 05 06 6 0.6 0.00 000 00 83.3 (83. 88. 09 (IAPSI 87. 0.0 83. (83 (8 (

Objective: To investigating the relationship between α-Klotho and FGF-23 with bone biochemical markers and bone density findings in extremely aged individuals. Methods: A total of 55 individuals with a mean age of 85.6 years were subjected to clinical, biochemical, and bone mineral density analyses and the enzyme-linked immunosorbent assay-based detection of α-Klotho and FGF-23. The mean, standard deviation, median, and interquartile ranges of the sample values were determined, and Spearman's test for association assessments was used for statistical analysis. Results: The study participants expressed median FGF-23 and α-Klotho levels of 69.81 RU/mL (51.43 RU/mL) and 733.43 pg/mL (360.83 pg/mL), respectively. The majority of the participants possessed osteopenia (54.5%) and a vitamin D deficiency (57%). The 25-hydroxyvitamin D concentrations ranged between 7.1 and 47.5ng/mL, with a median of 18.1ng/mL. Conclusion: No substantial associations were discovered between α-Klotho and FGF-23 levels and bone density in the study participants. Objective αKlotho α Klotho FGF23 FGF 23 FGF-2 Methods 5 856 85 6 85. clinical enzymelinked enzyme linked assaybased assay based FGF23. 23. deviation determined Spearmans Spearman s analysis Results 6981 69 81 69.8 RUmL RU mL 51.43 5143 51 43 (51.4 73343 733 733.4 pgmL pg 360.83 36083 360 83 (360.8 pg/mL, , pg/mL) respectively 54.5% 545 54 (54.5% 57%. 57 57% . (57%) 25hydroxyvitamin hydroxyvitamin 25 71 7 1 7. 475ngmL ngmL 47 5ng ng 47.5ng/mL 181ngmL 18 1ng 18.1ng/mL Conclusion FGF2 2 FGF- 8 698 69. 51.4 514 4 (51. 7334 73 733. 360.8 3608 36 (360. 54.5 (54.5 (57% 51. (51 360. 3 (360 54. (54. (57 (5 (36 (54 ( (3

RESUMO JUSTIFICATIVA E OBJETIVOS: O tapentadol de liberação prolongada (LP) demonstrou eficácia, segurança e boa tolerabilidade para o tratamento de dor crônica moderada a grave em pacientes com mais de 65 anos de idade. O objetivo deste estudo foi descrever três casos clínicos em que o tapentadol de liberação prolongada foi usado como tratamento para dor crônica de moderada a grave em indivíduos de 75 a 83 anos de idade. RELATO DOS CASOS: Dois pacientes do sexo feminino (75 e 83 anos de idade) e um paciente do sexo masculino (78 anos de idade) com dor osteoarticular crônica ou dor lombar de intensidade moderada a intensa e com limitação funcional, que haviam sido submetidos a tratamentos anteriores sem sucesso e estavam limitados funcionalmente, foram submetidos a tratamento com tapentadol LP. O tapentadol LP foi associado a uma melhora considerável da dor em todos os três pacientes, levando a uma maior independência na realização das atividades diárias. Além disso, o uso do tapentadol LP não causou nenhum efeito adverso significativo. CONCLUSÃO: O tratamento com tapentadol parece ser eficaz e tolerável no tratamento da dor crônica moderada a grave em pacientes idosos. OBJETIVOS (LP eficácia 6 idade 7 8 CASOS (7 78 funcional funcionalmente diárias disso significativo CONCLUSÃO idosos (

ABSTRACT BACKGROUND AND OBJECTIVES: Prolonged-release (PR) tapentadol has demonstrated efficacy, safety, and good tolerability for the management of moderate to severe chronic pain in patients over 65 years of age. The objective of this study was to describe three clinical cases in which tapentadol PR was used as treatment of moderate to severe chronic pain in individuals aged 75 to 83 years old. CASE REPORT: Two female patients (75 and 83 years old) and one male patient (78 years old) with chronic osteoarticular pain or low back pain of moderate to severe intensities and with functional limitation, who had undergone previous unsuccessful treatments and were functionally limited, underwent treatment with tapentadol PR. Tapentadol PR was associated with considerable improvement of pain in all three patients, leading to greater independence in performing daily activities. In addition, the use of tapentadol PR did not cause any significant adverse effects. CONCLUSION: Treatment with tapentadol PR seems to be effective and tolerable in the management of moderate to severe chronic pain in senior patients. OBJECTIVES Prolongedrelease Prolonged release (PR efficacy safety 6 age 7 8 old REPORT (7 78 limitation limited activities addition effects CONCLUSION (

Resumo Antecedentes Embora existam várias formas de estimar a dor na demência ainda há necessidade de ferramentas com melhores itens para avaliação da presença e intensidade da dor nesses indivíduos. Objetivo Analisar as propriedades psicométricas de uma ferramenta de avaliação da dor em idosos dementados, a “Pain Intensity Measure for Persons with Dementia Portuguese - PIMD-p”. Métodos Idosos expostos a situações potencialmente dolorosas, sendo esses dementados e com prejuízo na comunicação verbal, foram selecionados em uma unidade ambulatorial e uma instituição de longa permanência, em São Paulo. A PIMD-p foi aplicada por 2 pesquisadores (E1 e E2), de forma separada, num mesmo dia, e, com intervalo de no máximo 14 dias, essa foi reaplicada por apenas um deles (E3), e ainda, foi obtida a intensidade álgica inferida pelos cuidadores dos idosos participantes. Na análise estatística foram utilizados o Alfa de Cronbach, o Coeficiente de Spearman e o Índice de Correlação Intraclasses. Resultados Selecionada uma amostra de 50 idosos com média de idade de 86 anos, a maioria portadora de demência moderada e de dor de origem musculoesquelética. Apuradas para a PIMD-p uma boa consistência interna, segundo o alfa Cronbach (0,838); excelentes reprodutibilidades intra e interobservador (0,927 e 0,970, respectivamente; p < 0,001); e uma validade convergente, essa última obtida com as fortes e significativas correlações entre as intensidades dolorosas inferidas e os indicadores de dor do instrumento em estudo (exceto para o indicador “olhar expressivo”; corr = 0,106 e p = 0,462). Conclusão A PIMD-p se mostrou ser uma ferramenta com propriedades de medida adequadas para avaliar a presença e intensidade álgicas em idosos com demência e com prejuízo na comunicação verbal. indivíduos Pain PIMDp. PIMDp PIMD . PIMD-p” verbal permanência Paulo E1 E (E E2, E2 , E2) separada dia 1 dias E3, E3 (E3) participantes Intraclasses 5 8 anos musculoesquelética interna 0,838 0838 0 838 (0,838) 0,927 0927 927 (0,92 0970 970 0,970 respectivamente 0,001 0001 001 0,001) convergente exceto olhar expressivo expressivo” 0106 106 0,10 0,462. 0462 0,462 462 0,462) (E3 0,83 083 83 (0,838 0,92 092 92 (0,9 097 97 0,97 0,00 000 00 010 10 0,1 046 0,46 46 0,8 08 (0,83 0,9 09 9 (0, 0,0 01 0, 04 0,4 4 (0,8 (0 (

Abstract Background Although there are several ways to assess pain in dementia, there is still a need for tools with better items to assess the presence of pain intensity in these individuals. Objective To validate to Brazilian version of the “Pain Intensity Measure for Persons with Dementia – PIMD-p. Methods Older adults, all demented with impaired verbal communication and exposed to potentially painful situations, were selected from an outpatient clinic and long-term care facility (LTCF). The PIMD-p was applied independently by 2 researchers (E1 and E2) on the same day. Within 14 days, the instrument was reapplied by one of the 2 researchers (E3). The pain intensity reported by participants' caregivers and LTCF nurses were recorded on a verbal numeric pain scale. For the statistical analysis, Cronbach's Alpha, Spearman's Coefficient and intraclass correlation Index were calculated. Results A total of 50 older individuals were selected (mean age 86 years), majority with musculoskeletal pain. The PIMD-p demonstrated good internal consistency according to Cronbach's α (0.838), excellent intra and interobserver reproducibility (0.927 and 0.970, respectively; p < 0.001), and convergent validity (strong significant correlations between reported pain intensities and pain indicators on the PIMD-p (except for expressive eyes; corr = 0.106 and p = 0.462). A ROC curve was plotted to determine the best cut-off for the PIMD-P, and a score of 7.5 predicted moderate-to-severe pain, with 77.8% sensitivity and 95.7% specificity (p < 0.001). Conclusion The PIMD-p showed satisfactory psychometric properties for measuring intensity of pain in demented older adults with impaired verbal communication. dementia Pain PIMDp. PIMDp PIMD p. situations longterm long term LTCF. . (LTCF) E1 E (E E2 day 1 days E3. E3 (E3) participants scale analysis Cronbachs Cronbach s Alpha Spearmans Spearman calculated 5 mean 8 years, years , years) 0.838, 0838 0.838 0 838 (0.838) 0.927 0927 927 (0.92 0970 970 0.970 respectively 0.001, 0001 0.001 001 0.001) strong except eyes 0106 106 0.10 0.462. 0462 0.462 462 0.462) cutoff cut off PIMDP, PIMDP P, P PIMD-P 75 7 7. moderatetosevere moderate severe 778 77 77.8 957 95 95.7 0.001. (LTCF (E3 083 0.83 83 (0.838 0.92 092 92 (0.9 097 97 0.97 000 0.00 00 010 10 0.1 046 0.46 46 77. 9 95. 08 0.8 (0.83 0.9 09 (0. 0.0 01 0. 04 0.4 4 (0.8 (0 (

ABSTRACT BACKGROUND: Osteoporosis compromises bone strength and increases the risk of fractures. Zoledronate prevents loss of bone mass and reduces the risk of fractures. OBJECTIVES: To determine the efficacy and safety of zoledronate in postmenopausal women with osteopenia and osteoporosis. DESIGN AND SETTINGS A systematic review and meta-analysis was conducted within the evidence-based health program at the Universidade Federal de São Paulo. METHODS: An electronic search of the CENTRAL, MEDLINE, Embase, and LILACS databases was performed until February 2022. Randomized controlled trials comparing zoledronate with placebo or other bisphosphonates were included. Standard methodological procedures were performed according to the Cochrane Handbook and the certainty of evidence for the Grading of Recommendations Assessment, Development, and Evaluation Working Group. Two authors assessed the risk of bias and extracted data on fractures, adverse events, bone turnover markers (BTM), and bone mineral density (BMD). RESULTS: Twelve trials from 6,652 records were included: nine compared zoledronate with placebo, two trials compared zoledronate with alendronate, and one trial compared zoledronate with ibandronate. Zoledronate reduced the incidence of fractures in osteoporotic [three years: morphometric vertebral fractures (relative risk, RR = 0.30 (95% confidence interval, CI: 0.24–0.38))] and osteopenic women [six years: morphometric vertebral fractures (RR = 0.39 (95%CI: 0.25–0.61))], increased incidence of post-dose symptoms [RR = 2.56 (95%CI: 1.80–3.65)], but not serious adverse events [RR = 0.97 (95%CI: 0.91–1.04)]. Zoledronate reduced BTM and increased BMD in osteoporotic and osteopenic women. CONCLUSION: This review supports the efficacy and safety of zoledronate in postmenopausal women with osteopenia for six years and osteoporosis for three years. PROSPERO REGISTRATION NUMBER: CRD42022309708, https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=309708. BACKGROUND OBJECTIVES metaanalysis meta analysis evidencebased based Paulo METHODS CENTRAL MEDLINE Embase 2022 included Assessment Development Group BTM, , (BTM) BMD. . (BMD) RESULTS 6652 6 652 6,65 alendronate ibandronate relative 030 0 30 0.3 95% 95 (95 interval CI 0.24–0.38 024038 24 38 0.24–0.38)) 039 39 95%CI 95CI (95%CI 0.25–0.61, 025061 0.25–0.61 25 61 0.25–0.61))] postdose post dose 256 2 56 2.5 1.80–3.65, 180365 1.80–3.65 1 80 3 65 1.80–3.65)] 097 97 0.9 0.91–1.04. 091104 0.91–1.04 91 04 0.91–1.04)] CONCLUSION NUMBER CRD42022309708 CRD https//www.crd.york.ac.uk/prospero/display_record.phpRecordID=309708. httpswwwcrdyorkacukprosperodisplayrecordphpRecordID309708 httpswwwcrdyorkacukprosperodisplayrecordphpRecordID https //www.crd.york.ac.uk/prospero/display_record.php RecordID=309708. www crd york ac uk prospero display record php RecordID 309708 https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=309708 202 (BTM (BMD 665 6,6 03 0. 9 (9 0.24–0.3 02403 0.24–0.38) 02506 0.25–0.6 0.25–0.61)) 5 2. 18036 1.80–3.6 8 1.80–3.65) 09 09110 0.91–1.0 0.91–1.04) CRD4202230970 phpRecordID https//www.crd.york.ac.uk/prospero/display_record.phpRecordID=309708 httpswwwcrdyorkacukprosperodisplayrecordphpRecordID30970 wwwcrdyorkacukprosperodisplayrecordphp RecordID309708 RecordID=309708 30970 https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=30970 20 66 6, ( 0.24–0. 0240 0250 0.25–0. 0.25–0.61) 1803 1.80–3. 0911 0.91–1. CRD420223097 https//www.crd.york.ac.uk/prospero/display_record.phpRecordID=30970 httpswwwcrdyorkacukprosperodisplayrecordphpRecordID3097 RecordID30970 RecordID=30970 3097 https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=3097 0.24–0 024 025 0.25–0 180 1.80–3 091 0.91–1 CRD42022309 https//www.crd.york.ac.uk/prospero/display_record.phpRecordID=3097 httpswwwcrdyorkacukprosperodisplayrecordphpRecordID309 RecordID3097 RecordID=3097 309 https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=309 0.24– 02 0.25– 18 1.80– 0.91– CRD4202230 https//www.crd.york.ac.uk/prospero/display_record.phpRecordID=309 httpswwwcrdyorkacukprosperodisplayrecordphpRecordID30 RecordID309 RecordID=309 https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=30 0.24 0.25 1.80 0.91 CRD420223 https//www.crd.york.ac.uk/prospero/display_record.phpRecordID=30 httpswwwcrdyorkacukprosperodisplayrecordphpRecordID3 RecordID30 RecordID=30 https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=3 0.2 1.8 CRD42022 https//www.crd.york.ac.uk/prospero/display_record.phpRecordID=3 RecordID3 RecordID=3 https://www.crd.york.ac.uk/prospero/display_record.php?RecordID= 1. CRD4202 https//www.crd.york.ac.uk/prospero/display_record.phpRecordID= RecordID= https://www.crd.york.ac.uk/prospero/display_record.php?RecordID CRD420 https//www.crd.york.ac.uk/prospero/display_record.phpRecordID CRD42 CRD4

RESUMEN Objetivos: evaluar las evidencias de confiabilidad y validez convergente de constructo del King’s Parkinson’s Disease Pain Questionnaire. Métodos: estudio psicométrico con 75 adultos mayores con enfermedad de Parkinson. El instrumento fue aplicado por dos investigadores por separado y vuelto a aplicar por uno investigador después de 15 días. En cuanto a la confiabilidad, se evaluó la consistencia interna mediante la prueba alfa de Cronbach y la estabilidad mediante el coeficiente de correlación intraclase. Al evaluar la validez del constructo, las puntuaciones del King’s Parkinson’s Disease Pain Questionnaire se compararon con las de la Geriatric Pain Measure. Resultados: se obtuvo un alfa de Cronbach promedio entre las tres evaluaciones por encima de 0,60 y correlación intraclase por encima de 0,90, y una correlación débil pero significativa entre las dos escalas aplicadas. Conclusiones: el instrumento mostró evidencia adecuada de validez convergente de constructo y confiabilidad, y puede ser utilizado en la práctica clínica. Objetivos Kings King s Parkinsons Parkinson Métodos 7 1 días Measure Resultados 060 0 60 0,6 090 90 0,90 aplicadas Conclusiones clínica 06 6 0, 09 9 0,9

ABSTRACT Objectives: to assess the evidence of reliability and convergent construct validity of the King’s Parkinson’s Disease Pain Questionnaire. Methods: psychometric study of 75 older adults with Parkinson’s disease. The instrument was applied by two researchers separately and reapplied by one researcher 15 days later. In terms of reliability, internal consistency was assessed using the Cronbach’s alpha test and stability using the intraclass correlation coefficient. Scores of the King’s Parkinson’s Disease Pain Questionnaire were compared to those of the Geriatric Pain Measure in the assessment of construct validity. Results: the mean Cronbach’s alpha obtained between the three assessments was above 0.60, the intraclass correlation between the three assessments was above 0.90, and there was a weak but significant correlation between the two applied scales. Conclusions: the instrument showed adequate evidence of convergent construct validity and reliability, and can be used in clinical practice. Objectives Kings King s Parkinsons Parkinson Methods 7 disease 1 later Cronbachs Cronbach coefficient Results 060 0 60 0.60 090 90 0.90 scales Conclusions practice 06 6 0.6 09 9 0.9 0.

RESUMO Objetivos: avaliar as evidências de confiabilidade e de validade de construto convergente do King’s Parkinson’s Disease Pain Questionnaire. Métodos: estudo psicométrico com 75 idosos com doença Parkinson. O instrumento foi aplicado por dois pesquisadores separadamente e reaplicado por um dos pesquisadores após 15 dias. Na confiabilidade, a consistência interna foi avaliada pelo teste de alfa de Cronbach e a estabilidade pelo coeficiente de correlação intraclasse. Na avaliação da validade de construto, os escores do King’s Parkinson’s Disease Pain Questionnaire foram comparados ao escore da Geriatric Pain Measure. Resultados: foi obtido um alfa de Cronbach médio entre as três avaliações acima de 0,60 e correlação intraclasse entre as três avaliações acima de 0,90, bem como uma correlação fraca, mas significativa entre as duas escalas aplicadas. Conclusões: o instrumento apresentou adequadas evidências de validade de construto convergente e de confiabilidade, podendo ser utilizado na prática clínica. Objetivos Kings King s Parkinsons Parkinson Métodos 7 1 dias Measure Resultados 060 0 60 0,6 090 90 0,90 fraca aplicadas Conclusões clínica 06 6 0, 09 9 0,9

ABSTRACT Objective To develop a short version of the 25-question Geriatric Locomotive Function Scale-Portuguese and to create an algorithm for locomotive syndrome screening and management. Methods The 25-question Geriatric Locomotive Function Scale-Portuguese was applied to individuals aged 60 years or older seen at the Geriatrics and Gerontology Department of Universidade Federal de São Paulo, between 2016 and 2018. Items of the 25-question Geriatric Locomotive Function Scale-Portuguese were submitted to exploratory factor analysis using the principal component method. Internal consistency was investigated using Cronbach’s alpha coefficient. The ROC curve was used to determine the cut-off point of the short version developed. Finally, a simple and objective algorithm was created for locomotive syndrome screening and management using the Delphi method. Results A total of 202 elderly individuals aged 61 to 101 years (mean age, 84.67 years) were evaluated. Fifteen items were excluded from the 25-question Geriatric Locomotive Function Scale-Portuguese to compose the 10-question Geriatric Locomotive Function Scale-Portuguese, a 10-item instrument with appropriate psychometric properties. A cut-off point of ten (ROC curve) was determined for potential locomotive syndrome, with 96.5% sensitivity and 86.2% specificity. A very simple algorithm was developed for locomotive syndrome screening and management. Conclusion The short version (10-question) of the Geriatric Locomotive Function Scale-Portuguese has appropriate psychometric properties and provides a practical tool for detection of locomotive problems in elderly individuals.

RESUMO Introdução: A co-ocorrência de dor crônica e de distúrbios do sono contribuem para um impacto funcional e social negativo em idosos. Porém, o binômio dor-sono não foi explorado em relação a questionários para idosos, a fim de auxiliar na triagem, no diagnóstico ou no monitoramento da eficácia do tratamento médico. Objetivo: Desenvolver e validar um instrumento breve, prático e abrangente para avaliar a concorrência de condições álgicas crônicas e distúrbios de sono em idosos. Métodos: Estudo descritivo e qualitativo de metodologia de desenvolvimento e validação de instrumento de medida para avaliação de dor e sono em idosos, composto por sete itens. Após a fundamentação teórica, desenvolveram-se os itens do instrumento, seguidos de um estudo quantitativo (validação), em que testamos pacientes idosos com dor crônica. Resultados: Aplicou-se o Instrumento de Avaliação de Sono para Dor em Idosos (IASID) a uma amostra de 100 idosos. Alcançou-se o alfa de Cronbach (0,602) de boa homogeneidade por correlação item-total (≥0,4). Encontramos correlações estatisticamente significativas entre o IASID e a qualidade do sono (PSQI, r=61,5%); a intensidade da dor (NVS, r=30,5%); seus impactos (GPM, r=40,5); depressão (GEAP, r=45,5%); comorbidades (r=27,9) e uso de medicamentos (r=30,4). A curva ROC apontou sensibilidade de 73,2% e especificidade de 79,1% para predição de distúrbios do sono associados à dor crônica em idosos. Conclusões: O IASID apresentou propriedades métricas adequadas e demonstrou ser uma ferramenta simples e prática para a avaliação do impacto da dor no sono em idosos.

Abstract Background: The co-occurrence of chronic pain and sleep disturbance contribute to a significant functional and social impact in older adults. However, there are no validated instruments to measure sleep disturbance and pain in this population that could be used to screen or diagnose individuals or monitor treatment effectiveness. Objective: Our aim was to develop and validate a brief, practical, and comprehensive tool to assess the impact of co-occurring pain and sleep disturbance in older adults. Methods: Development and validation of a measurement tool for assessing pain and sleep in older adults consisting of seven items. Results: We applied the “Sleep Assessment Instrument for Pain in older adults” (SAIOAP) in a sample of 100 older individuals. A Cronbach’s alpha of 0.602 indicated a moderate level of reliability, and item-total correlations of ≥0.4 for all items indicated good homogeneity. There were statistically significant correlations between the SAIOAP and sleep quality (PSQI, r=61.5), pain intensity (VNS, r=30.5), the multidimensional impacts of pain (GPM, r=40.5), depression (GEAP, r=45.5), comorbidity (r=27.9), and medication use (r=30.4). A ROC curve indicated a sensitivity of 73.2% and a specificity of 79.1% in relation to the prediction of sleep disturbances associated with pain in older adults. Conclusions: The SAIOAP presented adequate metric properties and was demonstrated to be a simple and practical tool for the assessment of the impact of pain on sleep in older adults.

ABSTRACT BACKGROUND: Fatigue is a frequent symptom in patients with primary Sjögren’s syndrome (pSS) and can be a cause of or be associated with sleep disorders. OBJECTIVE: To assess the sleep quality of pSS patients and its relationship with fatigue and disease activity. DESIGN AND SETTING: Analytical observational study conducted at an exercise psychobiology laboratory. METHODS: Sleep quality was evaluated using the Pittsburg sleep quality index (PSQI) and actigraphy. Fatigue was evaluated through the Profile of Fatigue and Discomfort - Sicca Symptoms Inventory (PROFAD-SSI-SF) and a visual analogue scale for fatigue (VAS-fatigue). Disease activity was evaluated using a visual analogue scale for pain (VAS-pain), EULAR Sjögren’s Syndrome Patient Reported Index (ESSPRI) and Disease Activity Index (ESSDAI). We summarized the data through descriptive statistics. RESULTS: A total of 50 female patients with pSS, of average age 56.4 years, were included in the study; 80% presented low disease activity. The total PSQI score showed that 74% had poor sleep. The actigraphy showed mean sleep latency of 26.2 minutes and mean nightly awakening of 48.2 minutes (duration of wakings after sleep onset, WASO). There were correlations between PSQI and VAS-pain, VAS-fatigue, PROFAD-SSI and ESSPRI. Actigraphy showed a correlation between the duration of WASO and ESSDAI. CONCLUSION: The present study provides important information regarding correlations between sleep disorders and disease activity. There is a need for proper control over disease activity and for development of strategies to help patients to sleep better in order to diminish their fatigue.

Resumo Objetivos: avaliar a frequência de transtornos de ansiedade em idosos longevos com dor crônica e verificar as suas associações. Método: estudo descritivo, analítico e de corte transversal do "Projeto Longevos", do qual participam idosos da comunidade com 80 anos de idade ou mais. Selecionados os longevos com dor crônica dos quais se apuraram as características sociodemográficas e os aspectos referentes à dor, principalmente aqueles relacionados às suas multidimensões, segundo o Geriatric Pain Measure-p (GPM-p). Foram realizadas avaliações de funcionalidade e autopercepção de saúde, e os rastreios dos transtornos de depressão e ansiedade, segundo a Escala de Depressão Geriátrica e o Inventário de Ansiedade Traço-Estado, respectivamente. As associações foram analisadas segundo a correlação de Pearson, o teste de Anova e o Teste de comparações múltiplas de Tukey. Resultados: amostra constituída por 41 idosos com média de idade de 85,7 anos, sendo a maioria do sexo feminino, branca, viúva e de baixa escolaridade. Observadas altas prevalências de transtornos de ansiedade, 53,6% e 68,3%, respectivamente, traço e estado de ansiedade. Foi observada correlação significativa, mas não alta, da ansiedade-traço com a dor crônica segundo o GPM-p (r=31,5%; p=0,048) e correlação significativa e alta desse mesmo tipo de ansiedade com a depressão (r=61,3%; p<0,001). Conclusão: os transtornos de ansiedade foram muito prevalentes nos longevos com dor crônica, e esses se correlacionaram significativamente com a dor e a depressão, o que poderia justificar a necessidade de medidas terapêuticas multidisciplinares e diferentes nos quadros álgicos persistentes de idosos.

Abstract Objectives: to evaluate the frequency of anxiety disorders in older elderly persons with chronic pain and identify associated factors. Method: a descriptive, analytical and cross section study of the "Projeto Longevos" ("Long-Lived Elderly Persons Project") was carried out, featuring elderly persons living in the community who were aged 80 or over. Older elderly persons with chronic pain were selected, and data regarding their sociodemographic characteristics and factors related to pain was gathered, especially with regard to the multidimensional nature of pain, according to the "Geriatric Pain Measure-p" (GPM-p). Self-perception of health was also recorded and functionality assessments were carried out, along with the screenings for depression and anxiety disorders, according to the Geriatric Depression Scale and the State-Trait Anxiety Inventory, respectively. Associations were analyzed by Pearson correlation, the ANOVA Test and Tukey multiple comparisons. Results: the sample was composed of 41 elderly persons with a mean age of 85.7 years, most of whom were female, white, widowed and had a low education. A high prevalence of anxiety disorders was observed, being 53.6% and 68.3%, respectively, for trait and state anxiety. A significant, but not high, correlation was found between the anxiety trait and chronic pain according to the GPM-p (r=31.5%; p=0.048), and there was a significant and high correlation between the same type of anxiety and depression (r=61.3%; p<0.001). Conclusion: anxiety disorders were very prevalent in older elderly persons with chronic pain, and these correlated significantly with pain and depression, which could justify the need for varied multidisciplinary therapeutic measures against the persistent pain conditions of the elderly.

RESUMO Objetivo: O termo síndrome locomotora (SL) designa condições nas quais os idosos apresentam alto risco de incapacidade para deambulação em decorrência de problemas em órgãos locomotores. Para seu rastreio foi criado o 25-Question Geriatric Locomotive Function Scale (GLFS-25). Objetivou-se aqui, traduzir, adaptar transculturalmente para o Brasil e estudar as propriedades psicométricas do GLFS-25. Método: Feitas tradução e adaptação transcultural do GLFS-25 que originaram o GLFS 25-P, cujas propriedades psicométricas foram analisadas numa amostra de 100 idosos. Apurados dados sociodemográficos relativos a dor, queda, autopercepção da saúde e funcionalidades básica e instrumental. O GLFS 25-P foi aplicado em três momentos: num mesmo dia por dois entrevistadores e após 15 dias novamente pelo primeiro entrevistador. Resultado: O GLFS 25-P apresentou alto valor de consistência interna, segundo o coeficiente Alfa de Cronbach (0,942); e reprodutibilidade ótima, segundo a correlação intraclasses: valores de 97,6% e 98,4%, interobservador e intraobservador, respectivamente (p < 0,01). As concordâncias para cada item do instrumento foram consideráveis (entre 0,248 e 0,673), segundo a estatística Kappa. Na validação, segundo o coeficiente de Pearson, foram obtidas correlações regular e boa para as atividades de vida diária básicas (AVDB) e instrumentais (AIVD), respectivamente (p < 0,01). Encontradas associações estatisticamente significantes com dor crônica (p < 0,001), queda (p = 0,02) e autopercepção de saúde (p < 0,001). A análise multivariada evidenciou risco de SL significativamente maior na presença de dor crônica (OR 15,92, IC 95% 3,08-82,27) e pior autopercepção de saúde (OR 0,23, IC 95% 0,07-0,79). Conclusão: O GLFS 25-P demonstrou ser confiável e válido no rastreio da SL em idosos.

ABSTRACT Objective: The term Locomotive Syndrome refers to conditions in which the elderly are at high risk of inability to ambulate due to problems in locomotor system. For Locomotive Syndrome screening, the 25-Question Geriatric Locomotive Function Scale was created. The objective here was to translate, adapt culturally to Brazil, and study the psychometric properties of 25-Question Geriatric Locomotive Function Scale. Method: The translation and cultural adaptation of 25-Question Geriatric Locomotive Function Scale were carried out, thus resulting in GLFS 25-P, whose psychometric properties were analyzed in a sample of 100 elderly subjects. Sociodemographic data on pain, falls, self-perceived health and basic and instrumental functionalities were determined. GLFS 25-P was applied three times: in one same day by two interviewers, and after 15 days, again by the first interviewer. Result: GLFS 25-P showed a high internal consistency value according to Cronbach's alpha coefficient (0.942), and excellent reproducibility, according to intraclass correlation, with interobserver and intraobserver values of 97.6% and 98.4%, respectively (p < 0.01). Agreements for each item of the instrument were considerable (between 0.248 and 0.673), according to Kappa statistic. In its validation, according to the Pearson's coefficient, regular and good correlations were obtained for the basic (BADL) and instrumental (IADL) activities of daily living, respectively (p < 0.01). Statistically significant associations with chronic pain (p < 0.001), falls (p = 0.02) and self-perceived health (p < 0.001) were found. A multivariate analysis showed a significantly higher risk of Locomotive Syndrome in the presence of chronic pain (OR 15.92, 95% CI 3.08–82.27) and with a worse self-perceived health (OR 0.23, 95% CI 0.07–0.79). Conclusion: GLFS 25-P proved to be a reliable and valid tool in Locomotive Syndrome screening for the elderly population.

RESUMO Objetivo: Estudar a qualidade do sono em longevos com dor crônica. Métodos: Foram investigados 51 longevos sem demência e com dor crônica de acordo com o Geriatric Pain Measure. Os questionários de Katz e Lawton foram utilizados para avaliar a funcionalidade. Para o rastreio de depressão foram usados o Geriatric Depression Scale e Geriatric Psychosocial Assessment of Pain-induced Depression. Auto-percepção e qualidade do sono, de acordo com o Pittsburgh Sleep Quality Index, também foram verificados. Resultados: Dor moderada foi observada em 64,7% dos participantes. O rastreamento de depressão foi positivo para 41,2% da amostra. Má qualidade do sono foi observada em 49% deles, entretanto 82,3% dos participantes tiveram uma muito boa ou boa auto-percepção do sono. Os principais fatores associados à má qualidade do sono foram mensuração da dor, auto-percepção ruim do sono e depressão induzida por dor. Conclusão: Os longevos com dor crônica e sem demência apresentam maior prevalência de sono de má qualidade, entretanto com superestimação desta. A má qualidade do sono foi associada com auto-percepção do sono ruim e depressão induzida por dor.

ABSTRACT Objective: To study the quality of sleep in very elderly people with chronic pain. Methods: We investigated 51 very elderly people without dementia and with chronic pain according to the Geriatric Pain Measure. Katz and Lawton questionnaires were used to evaluate functionality. The Geriatric Depression Scale and Geriatric Psychosocial Assessment of Pain-induced Depression were also used. Self-perceptions of sleep and quality of sleep were checked using the Pittsburgh Sleep Quality Index. Results: Moderate pain was seen in 64.7% participants. The tracking of depression was positive for 41.2%. Poor quality of sleep was noted in 49% of them, but 82.3% perceived that they had a very good, or a good, sleep. The main factors associated with poor sleep quality were measurement of pain, self-perception of sleep, and pain-induced depression. Conclusion: Very elderly people with chronic pain, and without dementia, had a higher prevalence of poor sleep; however, they overestimated their sleep quality. Poor quality of sleep was associated with a poor self-perception of sleep and pain-induced depression.

Resumo Objetivo: A fim de se introduzir no nosso meio um instrumento que permitisse uma avaliação clínica abrangente da depressão dor-induzida em idosos, propôs-se a tradução, adaptação transcultural para o Brasil e estudo das propriedades psicométricas do “Geriatric Psychosocial Assessment of Pain-induced Depression” (GEAP). Esse instrumento foi desenvolvido especialmente para rastreio da depressão associada à dor em idosos. Método: Foram realizadas tradução e adaptação transcultural do GEAP, cujas propriedades psicométricas foram analisadas em uma amostra de 48 idosos. Foram apurados dados sociodemográficos e relacionados a dor crônica, além de depressão. O GEAP-b foi aplicado em três momentos distintos, em um mesmo dia por dois entrevistadores diferentes (E1 e E2), e após 15 dias por um daqueles entrevistadores (E3). Resultados: O instrumento GEAP-b mostrou-se ser de fácil aplicação e alto valor de consistência interna, de acordo com o coeficiente alfa de Cronbach (0,835). Teve reprodutibilidade ótima, segundo as correlações intraclasses: valores de 98,5 e 92%, interobservador e intraobservador, respectivamente. As concordâncias para cada item do GEAP-b foram “consideráveis“ (entre 0,419 e 1,0), excetuando-se a concordância para o item 19, segundo a estatística kappa. Para a validade de critério do GEAP-b, correlações positivas e estatisticamente significativas foram obtidas para a dor, segundo o GPM-p (r=49,5%; p<0,001), e para a depressão, segundo o GDS (r=59%; p<0,001), com ambos os valores considerados regulares (entre 40 e 60%). Conclusão: O GEAP-b demonstrou ser confiável e válido no rastreio da depressão associada à dor em idosos.

Summary Objective: In order to introduce an instrument within our midst that allows a comprehensive clinical evaluation of pain-induced depression in the elderly, we proposed the translation, cross-cultural adaptation into Brazilian Portuguese, and study of the psychometric properties of the “Geriatric Psychosocial Assessment of Pain-induced Depression” (GEAP) scale. This instrument was especially developed for the screening of depression associated with chronic pain in the elderly. Method: We performed translation and cross-cultural adaptation of the GEAP scale, whose psychometric properties were analyzed in a sample of 48 elderly individuals. Sociodemographic data and information related to chronic pain were ascertained, as well as those related to depression. The GEAP-b scale was applied at three different times on the same day by two different interviewers (I1 and I2), and after 15 days by one of those interviewers (I3). Results: The GEAP-b proved to be an easy-to-apply instrument with a high internal consistency value, according to the Cronbach’s alpha coefficient (0.835). The reproducibility of the instrument was optimal, achieving intraclass correlations of 98.5 and 92% for interobserver and intraobserver, respectively. There was “considerable” agreement (between 0.419 and 1.0) for each GEAP-b item, except for item 19, according to the kappa statistic. As for the validity of the GEAP-b criterion, positive and statistically significant correlations were obtained for pain, according to GPM-p (r=49.5%, p<0.001), and depression, according to GDS (r=59%, p<0.001), both values being considered regular (between 40-60%). Conclusion: The GEAP-b scale has proven to be reliable and valid in the screening of pain-related depression in the elderly.

RESUMO Objetivo Validar o Pain Assessment Checklist for Seniors with Limited Ability to Communicate – Portuguese em idosos dementados e analisar as propriedades de suas medições. Métodos Foram avaliados 50 idosos dementados, residentes de uma casa de repouso e com capacidade de comunicação verbal limitada, quando expostos a situações potencialmente dolorosas. A ferramenta foi utilizada em dois momentos diferentes. Primeiro, foi aplicada por dois entrevistadores simultaneamente, e a intensidade da dor foi questionada com base na opinião do cuidador. Depois de 14 dias, sem intervenção de analgésico, a ferramenta foi aplicada novamente por um dos entrevistadores. Resultados A amostra teve predominância de mulheres, acima de 80 anos de idade, com demência de Alzheimer, apresentando dores musculoesqueléticas com intensidade moderada a grave. As propriedades psicométricas do instrumento demonstraram consistência interna adequada (coeficiente alfa de Cronbach de 0,827). A escala teve excelente reprodutibilidade, de acordo com o coeficiente de correlação intraclasse, e o instrumento demonstrou validade adequada. Conclusão O Pain Assessment Checklist for Seniors with Limited Ability to Communicate – Portuguese teve propriedades de medição adequadas para idosos com limitações de comunicação.

ABSTRACT Objective To validate the Pain Assessment Checklist for Seniors with Limited Ability to Communicate – Portuguese in demented elderly and to analyze its measurement properties. Methods We evaluated 50 elderly with dementia, residing in a nursing home and with limited communication ability, when exposed to potentially painful situations. The tool was applied at two different moments. First, two interviewers applied it simultaneously, and the intensity of pain was asked based on the caregiver’s opinion. After 14 days, with no analgesic intervention, one of the interviewers applied it again. Results The sample comprised more females, aged over 80 years, with dementia due to Alzheimer, presenting musculoskeletal pain of moderate to severe intensity. The psychometric properties of the tool demonstrated appropriate internal consistency (Cronbach’s alpha coefficient of 0.827). The scale had excellent reproducibility, according to the intraclass correlation coefficient, and the tool has been duly validated. Conclusion The Pain Assessment Checklist for Seniors with Limited Ability to Communicate – Portuguese had adequate measuring properties for use with elderly presenting limited communication.

RESUMO Objetivo Determinar a frequência com que os médicos abordam o assunto de sexualidade com seus pacientes mais idosos com dor crônica. Métodos Este é um estudo transversal, descritivo, analítico em que os médicos responderam a um questionário com perguntas relativas à abordagem de sexualidade nas consultas. Resultados Uma amostra de 155 médicos foi obtida, 63,9% afirmaram que não realizavam a abordagem da sexualidade e 23,2% afirmaram fazê-la na maior parte das vezes. As principais razões para não abordarem foram falta de tempo, medo de constranger o paciente e incapacidade técnica para abordar o assunto. Conclusão Existe uma necessidade de desenvolver estratégias para aumentar e melhorar a abordagem de sexualidade em idosos com dor crônica, de forma a melhorar sua qualidade de vida.

ABSTRACT Objective To determine the frequency with which physicians address their older adult patients with chronic pain about the issue of sexuality. Methods It is a cross sectional, descriptive, analytical study in which physicians answered a questionnaire comprising questions related to addressing the issue of sexuality during appointments. Results A sample of 155 physicians was obtained, 63.9% stated they did not address sexuality in medical interviews and 23.2% did it most of the time. The main reasons for not addressing were lack of time, fear of embarrassing the patient and technical inability to address the issue. Conclusion There is a need to develop strategies to increase and improve addressing of sexuality in elderly patients with chronic pain, in order to have better quality of life.